Ludovic Martinet

11
Documents

Publications

Publications

Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma

Jan Eckmann , Tanja Fauti , Marlene Biehl , Aintzane Zabaleta , Laura Blanco et al.

Blood, 2025, 145 (2), pp.202-219. ⟨10.1182/blood.2024025987⟩

Article dans une revue hal-05026338v1

NK cells with adhesion defects and reduced cytotoxic functions are associated with a poor prognosis in multiple myeloma

Eve Blanquart , Rüçhan Ekren , Bineta Rigaud , Marie-Véronique Joubert , Virginie Baylot et al.

Blood, 2024, 144 (12), pp.1271-1283. ⟨10.1182/blood.2023023529⟩

Article dans une revue hal-05026334v1
Deposit thumbnail

Impact of the Multiple Sclerosis-Associated Genetic Variant CD226 Gly307Ser on Human CD8 T-Cell Functions

Elena Morandi , Véronique Adoue , Isabelle Bernard , Ekaterina Friebel , Nicolas Nunez et al.

Neurology Neuroimmunology & Neuroinflammation, 2024, 11 (6), pp.e200306. ⟨10.1212/NXI.0000000000200306⟩

Article dans une revue hal-04780777v1

RAS/RAF landscape in monoclonal plasma cell conditions

Anais Schavgoulidze , Jill Corre , Mehmet Kemal Samur , Celine Mazzotti , Luka Pavageau et al.

Blood, 2024, 144 (2), pp.201-205. ⟨10.1182/blood.2023022295⟩

Article dans une revue hal-05026345v1
Deposit thumbnail

TCR-independent CD137 (4-1BB) signaling promotes CD8+-exhausted T cell proliferation and terminal differentiation

Andrea Pichler , Nadège Carrié , Marine Cuisinier , Samira Ghazali , Allison Voisin et al.

Immunity, 2023, 56 (7), pp.1631-1648.e10. ⟨10.1016/j.immuni.2023.06.007⟩

Article dans une revue hal-04975485v1

SAR442085, a novel anti-CD38 antibody with enhanced antitumor activity against multiple myeloma

Sahar Kassem , Béré Diallo , Nizar El-Murr , Nadège Carrié , Alexandre Tang et al.

Blood, 2022, 139 (8), pp.1160-1176. ⟨10.1182/blood.2021012448⟩

Article dans une revue hal-05026353v1

SAR442085, a novel anti-CD38 antibody with enhanced antitumor activity against multiple myeloma

Sahar Kassem , Béré Diallo , Nizar El-Murr , Nadège Carrié , Alexandre Tang et al.

Blood, 2022, 139 (8), pp.1160-1176. ⟨10.1182/blood.2021012448⟩

Article dans une revue hal-03983352v1
Deposit thumbnail

Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy

Marianne Weulersse , Assia Asrir , Andrea C Pichler , Lea Lemaitre , Matthias Braun et al.

Immunity, 2020, 53 (4), pp.824-839.e10. ⟨10.1016/j.immuni.2020.09.006⟩

Article dans une revue hal-03030829v1
Deposit thumbnail

Imprinting of Mesenchymal Stromal Cell Transcriptome Persists even after Treatment in Patients with Multiple Myeloma

Léa Lemaitre , Laura Do Souto Ferreira , Marie-Véronique Joubert , Hervé Avet-Loiseau , Ludovic Martinet et al.

International Journal of Molecular Sciences, 2020, 21 (11), pp.3854. ⟨10.3390/ijms21113854⟩

Article dans une revue hal-04693062v1

Chemotherapy followed by anti-CD137 mAb immunotherapy improves disease control in a mouse myeloma model

Camille Guillerey , Kyohei Nakamura , Andrea Pichler , Deborah Barkauskas , Sophie Krumeich et al.

JCI Insight, 2019, 4 (14), ⟨10.1172/jci.insight.125932⟩

Article dans une revue hal-05026492v1

TIGIT immune checkpoint blockade restores CD8+ T-cell immunity against multiple myeloma

Camille Guillerey , Heidi Harjunpää , Nadège Carrié , Sahar Kassem , Tricia Teo et al.

Blood, 2018, 132 (16), pp.1689-1694. ⟨10.1182/blood-2018-01-825265⟩

Article dans une revue hal-05026506v1